杂志简称：blood adv
中文译名：《血液研究进展》
收录属性：scie（2024版）, 目次收录（维普）, 目次收录（知网）,英文期刊,
自引率：5.10%
投稿方向：医学、hematology血液学
SCI/E期刊基本信息
出版周期：半月刊 地区：美国
中科院分区：2区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN 2473-9529；EISSN 2473-9537
杂志语言：英语
出版国家：美国
杂志官网 联系方式
出版地址：2021 L ST NW,SUITE 900,WASHINGTON,USA,DC,20036
杂志邮箱：
投稿网址：https://bloodadvances.msubmit.net/
杂志官方网址：https://ashpublications.org/bloodadvances
出版商网址：http://www.hematology.org
杂志投稿要求
投稿须知【杂志社官方网站信息】
Author Guide
Contents of Blood Advances Author Guide
Journal Scope – For specific information detailing Blood Advances’ scope with a newly added category on Health Services and Outcomes.
Article Types – For detailed descriptions of the various article types that will be considered for publication by Blood Advances.
Manuscript Preparation – For general requirements and recommendations for preparing your manuscript for submission including:
manuscript organization requirements
guidelines for image preparation
information on supplemental data
editing services for non-English speakers
Manuscript Submission – For a helpful list of what information you should have on hand before beginning the online submission process.
Peer Review – For details about Blood Advances' peer review process and policies, including instructions for reviewers.
Revised Manuscripts – For general information to prepare your revised manuscript.
Accepted Manuscripts – For procedures and policies related to your accepted manuscript including:
copyright transfer
file formatting
figure preparation
typeset requirements
cover illustrations
proofreading
Publication Fees – For a list of possible publication fees applicable for each article type, including details about our publication fee, supplemental data fee, and reprint fees.
Editorial Policies for Authors – For detailed descriptions of Blood Advances' policies regarding:
authorship criteria
conflict of interest disclosure
originality
publication of medical research involving human subjects
data sharing, distribution of reagents, and compound structure disclosure
deposition into public databases
clinical trial reporting and registry
guidelines for stem cell research
public access options for authors
submission of NIH-funded accepted manuscripts to PubMed Central
press embargo policy
Errata – For a brief description of errata, how they are utilized by Blood Advances, and instructions on how to submit an erratum request.
Journal Scope
Blood Advances, a Journal of the American Society of Hematology, published online and open access, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology and related sciences. Blood Advances will complement Blood by publishing content not currently covered including case reports, point-counterpoint discussions, and by providing forums to readily comment on published material. The electronic format of Blood Advances provides an opportunity to explore novel approaches for presentation of original content including the use of enhanced graphics, video and online discussion. Additionally, it is hoped that Blood Advances will serve as a hub for dissemination of educational and service needs by providing scholarly content and expert consultation requested by interested parties.
Acceptance of manuscripts is based on the originality or importance of the observations and investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well organized, and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.
Blood Advances has recently added a new scientific category for Health Services and Outcomes submissions. The journal is very interested in submissions as reflected in the definition here.
Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Health Services and Outcomes (new); Hematopoiesis and Stem Cells; Immunobiology; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate.
Authors are invited to contact the Editor-in-Chief prior to submission if they are uncertain whether their work falls within the general scope of the journal. For presubmission inquiries regarding the journal scope, please contact the Blood Advances Editorial Department and include an abstract or detailed summary for consideration.